CORONAVIRUS/Taiwan plans to allow mixing of AZ-BNT vaccines
Taipei, Oct. 21 (CNA) The government plans to authorize further COVID-19 vaccine mix-and-matching, by allowing those who received an AstraZeneca shot at least 10 weeks ago to choose the Pfizer-BioNTech (BNT) for their second dose during the next round of vaccinations, Health Minister Chen Shih-chung (陳時中) said Thursday.
The Central Epidemic Command Center (CECC) is expected to allow mixing and matching of those COVID-19 vaccines starting in early November, allowing people in all age groups who received an AZ vaccine jab at least 10 weeks ago to take the mRNA vaccine BNT as their second shot, Chen, who heads the CECC, said at a legislative session.
When asked how many people will be eligible for the mix-and-match approach, Chen said that about 1 million people have received an AZ shot and are waiting for their second dose.
The future shipment of vaccines Taiwan expects to receive are likely to be sufficient to meet demand for the upcoming 13th round of vaccinations, including mixed-doses of coronavirus vaccines, he added.
The Advisory Committee on Immunization Practices under the Ministry of Health and Welfare previously agreed to allow those in the first three vaccine priority groups who have received the AZ vaccine as their first dose to take mRNA vaccines such as BNT and Moderna for the second at an interval of at least eight weeks, according to a report given by Chen to the Legislative Yuan's Social Welfare and Environmental Hygiene Committee.
The top three priority groups in Taiwan are medical workers and frontline non-medical personnel working in medical facilities, epidemic prevention workers, and people at higher risk of exposure to COVID-19 due to their jobs.
Currently, medical workers and non-medical personnel working in medical facilities who received an AZ COVID-19 vaccine jab more than 10 weeks ago are allowed to take the Moderna vaccine as their second shot, according to the report.
However, Chen said that more research will need to be done before permission is given to mix the domestically-developed Medigen vaccine with other vaccines.
- Medigen gets funds from global foundation for mix-and-match booster trialsTaiwanese pharmaceutical company Medigen Vaccine Biologics Corp. said Thursday that it has received a US$2.3 million grant from an international foundation to fund trials of its ...12/02/2021 10:51 PM
- Taiwan begins nighttime vaccination, considering PX Mart vaccine sitesA number of hospitals in Taiwan have begun offering nighttime COVID-19 vaccination slots from Thursday, while the Central Epidemic Command Center (CECC) is also considering ...12/02/2021 06:20 PM
- Taiwan buys additional 5 million AZ doses, details booster shot rulesTaiwan signed a contract with AstraZeneca in November to purchase 5 million doses of the company's COVID-19 vaccine for the rollout of booster shots, Minister of Health and ...12/02/2021 05:42 PM
- Science & Tech
Medigen gets funds from global foundation for mix-and-match booster trials12/02/2021 10:51 PM
Taiwan badminton duo Lee and Wang keep Finals hope alive12/02/2021 10:27 PM
City councilor calls nuclear plant 'failed' investment project12/02/2021 10:08 PM
Taiwan basketballers hail entry to East Asia Super League12/02/2021 09:31 PM
Local securities firm chairman questioned by authorities12/02/2021 08:58 PM